Stevanato Group S.p.A.
NYSE:STVNMedical - Instruments & Supplies
+$0.67 today
- Market cap
- $4.20B
- Beta
- 0.78
- P/E (TTM)
- 29.9
- EPS (TTM)
- $0.52
- Dividend yield
- 0.35%
Volume 0.61M
Average 0.52M
STVN Total Equity
Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.
Stevanato Group S.p.A.NYSE: STVN
Total Equity · Q2 FY2026 · quarter ended Jun 2026
Total equity rises 10.9% from a year ago
Total equity stood at €1.55B at the end of Q2 FY2026, up 10.9% from a year earlier and up 1.2% from the prior quarter. Over 3 fiscal years it compounded at +14.3% a year.
Context
- Total equity amounted to 59.2% of total assets at the end of Q2 FY2026, down 0.3 pp from a year earlier.
- Total equity increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total equity keeps rising in the next quarterly balance sheet after a +10.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Equity history
EUR · from the balance sheet
- Latest · FY2025
- 1.49B EUR
- Year-over-year change
- +5.8%
- 4-year CAGR
- +15.3%
| Period | Period end | Total Equity | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.49B | +5.8% |
| FY2024 | 2024-12-31 | 1.4B | +24.0% |
| FY2023 | 2023-12-31 | 1.13B | +13.7% |
| FY2022 | 2022-12-31 | 995.91M | +18.3% |
| FY2021 | 2021-12-31 | 841.66M | — |
Total Equity vs competitors
How STVN compares with its peers on the latest reported figures
- Peers report in different currencies, so total equity is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +10.9% is the 5th highest of 11, against a peer median of -1.3%.
- Total equity amounts to 59.2% of total assets for STVN, versus a peer median of 48.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $6.44B USD | -1.0% | -2.8% | 46.5% | |
| Jun 2026 | $5.63B USD | -10.4% | +4.7% | 48.6% | |
| Jun 2026 | $2.9B USD | -31.5% | -8.1% | 42.8% | |
| Jun 2026 | $2.67B USD | -1.6% | +9.5% | 52.1% | |
| Sep 2026 | $2.19B USD | +20.0% | +34.0% | 34.9% | |
| Sep 2026 | $1.74B USD | +14.1% | +11.5% | — | |
| Jun 2026 | €1.55B EUR | +10.9% | +14.3% | 59.2% | |
| Mar 2026 | $1.17B USD | +16.2% | +39.2% | 88.2% | |
| Jun 2026 | $830.51M USD | -30.7% | +7.0% | 52.6% | |
| Apr 2026 | $788.9M USD | -16.6% | -18.6% | 48.0% | |
| Jun 2026 | $83.3M USD | +14.0% | -6.9% | 10.9% | |
| Peer median (excluding STVN) | — | -1.3% | +5.8% | 48.0% | |
Competitors are the stored peer set for STVN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 411.04M | 228.74M | 69.6M | 98.27M | 130.54M |
| Short-term Investments | 27.17M | 27.91M | 749K | 0 | 2.2M |
| Net Receivables | 278.42M | 369.48M | 522.48M | 529.87M | 542.17M |
| Inventory | 148.92M | 213.25M | 255.32M | 245.22M | 268.09M |
| Other Current Assets | 49K | 5.69M | 3.63M | 933K | (8.6M) |
| Total Current Assets | 865.97M | 845.78M | 861.89M | 880.12M | 934.4M |
| Property, Plant & Equipment (Net) | 415.41M | 660.69M | 1.05B | 1.26B | 1.4B |
| Goodwill | 47.24M | 47.24M | 49.98M | 49.98M | 49.96M |
| Intangible Assets | 31.93M | 32.16M | 30.99M | 33.59M | 36.85M |
| Long-term Investments | 1.97M | 1.83M | 5.15M | 5.64M | 6M |
| Tax Assets | 55.88M | 69.21M | 76.25M | 95.34M | 103.86M |
| Other Non-current Assets | 447K | 2.8M | 577K | 0 | 8.6M |
| Total Non-current Assets | 552.87M | 813.92M | 1.21B | 1.45B | 1.61B |
| Total Assets | 1.42B | 1.66B | 2.07B | 2.33B | 2.54B |
| Account Payables | 164.79M | 239.18M | 277.82M | 231.02M | 263.19M |
| Short-term Debt | 37.17M | 64.63M | 135.6M | 106.84M | 121.69M |
| Tax Payables | 27.82M | 42.09M | 30.82M | 32.06M | 0 |
| Deferred Revenue | 50.61M | 53.89M | 58.8M | 44.67M | 43.78M |
| Other Current Liabilities | 5.33M | (3.73M) | 11.15M | 15.45M | 106.91M |
| Total Current Liabilities | 338.62M | 462.5M | 574.39M | 477.47M | 535.57M |
| Long-term Debt | 183.99M | 133.75M | 242.05M | 305.23M | 337.64M |
| Deferred Tax Liabilities | 19.11M | 20.95M | 9.62M | 12.56M | 13.29M |
| Deferred Revenue (Non-current) | 0 | 0 | 39.42M | 44.05M | 98.76M |
| Other Non-current Liabilities | 17.9M | 31.93M | 60.35M | 73.32M | 62.07M |
| Total Non-current Liabilities | 238.56M | 201.29M | 364.54M | 446.96M | 521.38M |
| Total Liabilities | 577.18M | 663.79M | 938.93M | 924.43M | 1.06B |
| Common Stock | 21.7M | 21.7M | 21.7M | 22.23M | 22.22M |
| Retained Earnings | 0 | 623.35M | 757.86M | 863.44M | 876.41M |
| Accumulated OCI | 686.06M | (10.49M) | (9.11M) | (13.75M) | 54.95M |
| Other Stockholders Equity | 134.32M | 0 | 0 | 0 | 0 |
| Minority Interest | (415K) | (220K) | 115K | 46K | 37.98K |
| Total Equity | 841.66M | 995.91M | 1.13B | 1.4B | 1.49B |
| Total Debt | 244.29M | 218.37M | 396.59M | 428.97M | 470.7M |
| Net Debt | (166.75M) | (10.37M) | 326.99M | 330.7M | 340.16M |
Stevanato Group S.p.A.
NYSE:STVN
Intrinsic Alpha fair value
Locked
Current Price
$15.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.